Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb;143(2):228-36.
doi: 10.1111/j.1365-2249.2005.02991.x.

Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis

Affiliations

Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis

P Maerten et al. Clin Exp Immunol. 2006 Feb.

Abstract

4-1BB ligand (4-1BBL) expressed on antigen-presenting cells interacts with 4-1BB on activated T cells (especially CD8+ cells) and co-stimulates the latter to secrete cytokines and to proliferate. The role of 4-1BB-4-1BBL interaction was studied here in a model of colitis based on naive CD4+ T cell transfer to SCID mice, a disease model in which CD8 cells do not take part. We found that CD4+ T cells from 4-1BB-deficient mice, after transfer in SCID mice, proliferated more rapidly compared to wild-type CD4+ T cells. Mice reconstituted with naive CD4+ T cells from 4-1BB-deficient mice developed colitis, however, with a mixed Th1/Th2 response, in contrast to the Th1-type response in mice reconstituted with wild-type naive CD4+ T cells. Importantly, this altered cytokine response did not temper colitis severity. Although it has been reported previously that 4-1BB co-stimulation may contribute to regulatory T cell functioning, we found that CD4+CD25+ regulatory T cells from 4-1BB-deficient mice were perfectly able to prevent naive CD4+ T cell-induced colitis. In conclusion, our data provide evidence that 4-1BB-4-1BBL interaction modulates the effector CD4+ T cell-driven immune response and cytokine production in experimental colitis without affecting regulatory T cell function.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
In vivo homeostatic CD4+ T cell proliferation in the peritoneal cavity after transfer to SCID mice. CD4+ T cells were isolated from spleen cells of wild-type and 4-1BB–/– mice and stained with the cytoplasmic dye carboxyfluorescein succinimidyl ester (CFSE). (a) Unstained and CFSE-stained CD4+ T cells from 4-1BB–/– mice (left) and wild-type mice (right) as a negative and positive control, respectively. CFSE-stained cells were then injected intraperitoneally (i.p.) into SCID mice. At day 5, T cells were recovered from the peritoneal cavity and CFSE expression was analysed by flow cytofluorometry. (b) Representative FACS plots are shown; (c) summary bar graph representing the mean percentage plus s.e.m. of cells in the M1 and M2 area are shown (five mice per group). M1: cells which have undergone no or only few cell divisions; M2: cells which have undergo repeated cell divisions.
Fig. 2
Fig. 2
4-1BB expression in colon and mesenteric lymph nodes of wild-type CD45RBhiCD4+ T cell-reconstituted SCID mice. Microphotographs of cryostat sections of colons (a) and mesenteric lymph nodes (b) from wild-type CD45RBhiCD4+ T cell-reconstituted mice were stained with anti-mouse 4-1BB monoclonal antibodies (mAb) and peroxidase-labelled rabbit anti-rat and swine anti-rabbit Ig. (c) Microphotograph of a cryostat section of colon of a 4-1BB-deficient CD45RBhiCD4+ T cell-reconstituted SCID mice and stained as in (a) and (b). (d) Microphotograph of a cryostat section of colon from wild-type CD45RBhiCD4+ T cell-reconstituted SCID mice stained in the presence of a control primary antibody (original magnification × 400).
Fig. 3
Fig. 3
Comparison of disease activity after transfer of CD45RBhi and CD45RBlo CD4+ T cells from wild-type or 4-1BB–/– mice to SCID recipients. SCID mice were reconstituted with either wild-type or 4-1BB–/– CD45RBhiCD4+ T cells, or with wild-type CD45RBhiCD4+ T cells plus wild-type or 4-1BB–/– CD45RBloCD4+ T cells as indicated. Data from two independent experiments were pooled. (a) The change of weight over the observation time is expressed as a percentage of the original weight at the start of the experiment. Data represent the mean ± s.e.m. (b) Histological scores of colonic sections. Data represent the individual score for each mouse. ***P < 0·001. (a) ♦, CD45RBhi + 4-1BB+/+ CD45RBlo T cells (n = 7); ▿, CD45RBhi + 4-1BB-/- CD45RBlo T cells (n = 7); ▴, 4-1BB+/+ CD45RBhi T cells (n = 17); □, 4-1BB-/- CD45RBhi T cells (n = 18). (b) □, 4-1BB-/- CD45RBhi T cells (n = 18); ▴, 4-1BB+/+ CD45RBhi T cells (n = 17); ▿, CD45RBhi + 4-1BB-/- CD45RBlo T cells (n = 7); ♦, CD45RBhi+ + 4-1BB+/+ CD45RBlo T cells (n = 7).

References

    1. Vinay DS, Kwon BS. Role of 4-1BB in immune responses. Semin Immunol. 1998;10:481–9. - PubMed
    1. Alderson MR, Smith CA, Tough TW, et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol. 1994;24:2219–27. - PubMed
    1. Schwarz H, Valbracht J, Tuckwell J, von Kempis J, Lotz M. ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood. 1995;85:1043–52. - PubMed
    1. Kienzle G, von Kempis J. CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes. Int Immunol. 2000;12:73–82. - PubMed
    1. Melero I, Johnston JV, Shufford WW, Mittler RS, Chen L. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell Immunol. 1998;190:167–72. - PubMed

Publication types

MeSH terms